Detalhe da pesquisa
1.
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma.
Ann Oncol
; 33(3): 288-298, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34921960
2.
The importance of assessing blood tumour burden in cutaneous T-cell lymphoma.
Br J Dermatol
; 185(1): 19-25, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33155285
3.
Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial.
J Eur Acad Dermatol Venereol
; 35(11): 2225-2238, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34273208
4.
Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.
Ann Oncol
; 29(5): 1266-1272, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29444231
5.
Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.
Ann Oncol
; 29(12): 2363-2370, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30307529
6.
Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study.
HIV Med
; 2018 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29862615
7.
Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma.
Ann Oncol
; 28(9): 2169-2178, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28633365
8.
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.
Ann Oncol
; 28(10): 2517-2525, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961843
9.
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).
Ann Oncol
; 28(7): 1436-1447, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28379322
10.
A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine.
J Eur Acad Dermatol Venereol
; 36(10): e747-e749, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35617206
11.
Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndrome.
Br J Dermatol
; 175(1): 80-8, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26836950
12.
SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias.
Ann Oncol
; 25(12): 2339-2350, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24723488
13.
The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL).
Ann Oncol
; 25(2): 442-7, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24412823
14.
Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.
Ann Oncol
; 30(12): 2015, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31539020
15.
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.
Ann Oncol
; 30(3): 494, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29947731
16.
Radioimmunotherapy for first-line and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: an analysis of 215 patients registered in the international RIT-Network.
Eur J Nucl Med Mol Imaging
; 41(8): 1585-92, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24722703
17.
New therapies and old side-effects in mycosis fungoides treatment: brentuximab vedotin-induced alopecia.
Br J Dermatol
; 180(6): 1535-1536, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561000
18.
Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 29(Suppl 4): iv30-iv40, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29878045
19.
Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study.
Ann Oncol
; 24(11): 2892-7, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24030098
20.
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi.
Ann Oncol
; 24(8): 2108-12, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23585513